Skip to content
Open access

Autoimmune-mediated hypertriglyceridemia in a young male with refractory immune thrombocytopenia: a case report

Sep 2026 · Journal of Lipid Research · Vol 67 · 1 citation · 13 references
Medicine

Abstract

Severe hypertriglyceridemia (HTG), defined as triglyceride levels >500 mg/dl can cause acute pancreatitis and other metabolic complications. While primary forms are typically genetic, autoimmune-mediated HTG is rare. We report a 24-year-old male with refractory immune thrombocytopenia who developed severe HTG due to anti-GPIHBP1 autoantibodies. Conventional therapies, including plasmapheresis and immunosuppressive agents, were insufficient. Compassionate use of plozasiran, an RNA interference agent targeting APOC3, achieved an 80% reduction in triglyceride levels. This case highlights the importance of recognizing autoimmune GPIHBP1-mediated hypertriglyceridemia, as identifying the underlying mechanism may enable targeted therapy.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.